•    Chua K.K., Wong A., Kwan W.L., Song J.X., Chen L.L., Chan L.T., Bian Z.X., Mok V.* & Li M.* (2016) “A Pilot Randomized Controlled Trial of Chinese Medicine (Di-Tan Decoction) in Alzheimer’s disease”. J. Alzheimer Dis. & Parkins.2016 (In press)

•    Song J.X., Sun Y.R., Peluso I., Zeng Y., Yu X., Lu J.H., Liu L.F., Xu Z., Wang M.Z., Liu L.F., Huang Y.Y., Chen L.L., Durairajan S.S.K., Zhang H.J., Zhou B., Zhang H.Q., Lu A.P., Ballabio A., Guo Z.H.*, Diego M.,* & Li M.*(2016) “An novel TFEB activator promotes autophagy and lysosomal biogenesis in rat brain independent of mTOR inhibition”. Autophagy 2016; 12(8):1372-1389.

•    Tang Z., Liu L.F., Li Y.L., Dong J.Y., Li M., Huang J.D., Lin S.H., Cai Z.W.* (2016) “Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice”. Curr. Alzheimer Res. 2016; 13(7):764-76.

•    Nie S., Chong K., Li M.* (2016) “A study in general education: How a field trip for Chinese tea tasting motivates students’ learning”, Inter.J.Hum. Soc. Sci. & Edu. 2016, 3(1): 125-135.

•    Klionsky D.J., (…), Li M., (…), Lu J.H., (…), Song J.X., (…), et al. (2016) “Guidelines for the use and interpretation of assays for monitoring autophagy(3rd edition)”. Autophagy 2016; 12(1):1-222.

•    Liu L.F., Song J.X., Lu J.H., Huang Y.Y., Chen L. L., Duriarajan S.S.K., Han Q.B., Li M.* (2015) “Tianma Gouteng Yin, a Traditional Chinese Medicine decoction, exerts neuroprotective effects in animal and cellular models of Parkinson’s disease”. Sci. Rep. 2015; DOI: 10.1038/srep16862.

•    Friedemann T., Li M., Fei J., Schumacher U., Song J.X., Schröder S.* (2015)“Hypothesis driven screening of Chinese herbs for promoting neuroprotection”, Special Issue on “The Art and Science of Traditional Medicine” Part3: The Global Impact of Traditional Medicine. Science (Special issue), 2015; S69-71.

•    Luan H.M., Liu L.F., Tang Z., Mok V. C.T., Li M.,* Cai Z.W.* (2015) “Elevated excretion of biopyrrin as a new marker for idiopathic Parkinson's disease”, Parkinsonism Relat. Disord. 2015; DOI: http://dx.doi.org/10.1016/ j. parkreldis. 2015.09.009

•    Chen L., Song J.X., Luo Y.M., Li M.,* Gao L.* (2015) “Individualized Traditional Chinese Medicine Treatment of Acute Stroke”, Science (Special Issue: Translational Medicine at Capital Medical University: Investigating Major Chronic Disease) 17 July, 2015; P68-71.

•    Luan H.M., Liu L.F., Tang Z., Zhang M.W., Chua K.K., Song J.X., Mok V. C.T., Li M.,* Cai Z.W.* (2015) “Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease”, Sci. Rep.2015; DOI:10.1038/srep13888

•    Durairajan SSK*, Li M*,  Malampatti S, Zhang Y, Huang Y, Liu LF, Song, JX, Chen LL, Zeng Y, Senapati, S. (2015) “Protopine, A promising novel histone deacetylase 6 inhibitor reduces tauopathy in vitro and in vivo”, Neurodegener. Dis. 2015; 15(Suppl. 1): 352-1969-Page1579.

•    Nie S., Chong K., Thadani R.D., Li M.* (2015) “Lifestyle Changes through Chinese Medicine Education on Health Maintenance and Food Therapy among College Students”, Inter. J. Develop. Res. 2015; 5(6): 4762-4767.

•    Chua K.K., Wong A., Kwan W.L., Song J.X., Chen L.L., Chan L.T., Lu J.H., Mok V.,* Li M.* (2015) “The efficacy and safety of the Chinese herbal medicine Di-Tan Decoction on Alzheimer’s disease: study protocol for a randomized controlled trial”, Trials 2015, 16:199. DOI: 10.1186/s13063-015-0716-z

•    Ardah M.T., Paleologou K.E., Lv G.H., Khair S.B.A., Lu J.H., Al-Hayani A.A., Eliezer D., Li M., El-Agnaf O.M.A.*(2015) “Ginsenoside RB1 Inhibits Fibrillation and Toxicity of Alpha-synuclein and Disaggregates Preformed Fibrils”, Neurobiol. of Dis. 2015; 74:89-101.

•    Gao X.Y., Teng Y.L., Luo J.T., Huang L.G., Li M., Zhang Z.H., Ma Y.C., Ma L.*  (2015) “The survival motor neuron gene smn-1 interacts with the U2AF large subunit gene uaf-1 to regulate Caenorhabditis elegans lifespan and motor functions”, RNA Biology 2015; DOI:10.4161/ rna.36100.

•    Li J.J., Chua K.K., Li M.* (2015) “Constitutional Study of Parkinson’s Disease Patients Based on Traditional Chinese Medicine Pattern Differentiation”, Integra. Med. Inter. 2015; DOI: 10.1159/000369530.

•    Luan H.M., Liu L.F., Meng N., Tang Z., Chua K.K., Chen L.L., Song J.X., Mok V., Xie L.X., Li M.,* Cai Z.W.* (2015) “LC-MS-based Urinary Metabolite Signatures in Idiopathic Parkinson's Disease”, J. Proteome Res. 2015; 14, 467-478.

•    Chua K.K., Chen L.L., Liu L.F., Duriarajan S.S.K., Lu J.H., Li M.* (2014) “The Efficacy of Classical Chinese Medicine Formula Di-tan Decoction for Alzheimer’s disease”, Chin. J. Integr. Med. 2014; DOI: 10.1007/s11655-013- 1346.

•    Zhang X.B., Wang L., Li M. (2014) “The Literature Review of Chinese Medicine on the Treatment of Fatty Liver”, Hong Kong J. Tradit. Chin. Med. (Chin.) 2014; 9(4): 75-78.

•    Mok C.T., Chua K.K., Lau Y.K., Chan K.W., Chan K.H., Tse K.P., Chen L.L. Man S.C., Wong A., Chan A., Bian Z.X., Wu J., Li M.* (2014) “Randomized Clinical Trial Evaluating Effects of Traditional Chinese Medicine (Jia-Wei-Liu-Jun-Zi Tang) for Non-motor Symptoms in Parkinson’s Disease”, Mov. Disord. 2014; 29 (Suppl.1): P571

•    Lu J.H., He L.Q., Wang Q.J., Behrends C., Chait B.T., Yamamura K., Friedman S. L., Fiel M. I., Li M., Yue Z.Y. (2014) “NRBF2 Regulates Autophagy and Prevents Liver Lesions Through Modulating Beclin 1/Atg14L-Linked Class III Phosphatidylinositol-3 Kinase Activity”, Nat. Commun. 2014; 5:3920.

•    Chen L.L., Song J.X., Lu J.H., Yuan Z.W., Liu L.F., Duriarajan S.S.K., Li M.* (2014) “Corynoxine, a Natural Autophagy Enhancer, Promotes the Clearance of Alpha-synuclein via Akt/mTOR Pathway”, J. Neuroimmune. Pharma. 2014; 9:380-387.

•    Durairajan S.S.K.*, Huang Y.Y., Yuen P.Y., Chen L.L., Kwok K.Y., Liu L.F., Song J.X. Han Q.B., Xue L., Chung S.K., Huang J.D., Baum L., Senapati S., Li M.* (2014)“Effects of Huanglian-Jie-Du-Tang and Its Modified Formula on the Modulation of Amyloid-beta Precursor Protein Processing in Alzheimer's Disease Models ”, PLoS ONE 2014; 3(9): e92954.

•    Song J.X., Lu J.H., Liu L.F., Chen L. L., Durairajan S.S.K., Yue Z.Y., Zhang  H.Q*., Li M. * (2014) “HMGB1 is Involved in Autophagy Inhibition Caused by Alpha-synuclein Overexpression: a Process Modulated by the Natural Autophagy Inducer Corynoxine B”, Autophagy. 2014; 10(1):144-154.

•    Lin S.H., Kanawati B., Liu L.F., Witting M., Li M., Huang J.D., Schmitt-Kopplin P., Cai Z.W. (2014) “Ultrahigh Resolution Mass Spectrometry-based Metabolic Characterization Reveals Cerebellum as a Disturbed Region in Two Animal Models”, Talanta. 2014; 118: 45-53.

•    Kwok K.Y., Xu J., Ho H.M., Chen H.B., Li M., Lang Y., Han Q.B. (2013)“Quality Evaluation of Commercial Huang-Lian-Jie-Du-Tang based on Simultaneous Determination of Fourteen Major Chemical Constituents using High Performance Liquid Chromatography”, J. Pharm. Biomed. Anal. 2013; 85:239-244.

•    Chua K.K., Gao J., Kum W.F., Li M.* (2013) “Impact of Treatment-related Dyskinesias and Non-motor Symptoms on Quality of Life in Chinese Patients with Idiopathic Parkinson’s Disease”, Inter. J. Integra. Med. 2013; DOI: 10. 5772/56777

•    Si Y.W., Chua K.K., Li M. * (2013) “Literature review of the treatment of Chinese medicine on Motor Symptoms and Non-Symptoms of Parkinson’s disease”, Hong Kong J. Tradi. Chin. Med. (Chin.) 2013; 8(4): 27-29.

•    Durairajan S.S.K.,* Huang Y.Y., Chen L.L., Song J.X., Li M.* (2013). “Corynoxine isomers decrease levels of amyloid-beta peptide and amyloid-beta precursor protein by promoting autophagy and lysosome biogenesis”, Mol. Neurodegen. 2013; (Suppl. 1):P16. DOI: 10.1186/1750-1326-8-S1-P16.

•    Lin S.H., Kanawati B., Liu L.F., Liu H.D., Witting M., Li M., Huang J.D., Schmitt-Kopplin P., Cai Z.W.* (2013)“Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer's disease in CRND8 mice”, Anal Bioanal Chem. 2013; 405 (15): 5105-17.

•    Durairajan S.S.K.*, Chen L.L., Song J. X. Baum L., Li M.* (2013). “Corynoxine B, a Novel Autophagy Enhancer, Promotes the Clearance of Mutant Tau Aggregation in vitro and in vivo”, Neurodegen. Dis. 2013; Vol. 1, (Suppl.1): P120.

•    Pung L., Wang X.J., Li M., Xue L. (2013) “The role of APP in Alzheimer’s disease”, Advances in Alzheimer’s Dis. 2013; 2 (2):60-65.

•    Yuan Y.M., Li M.* (2013) “Literature review of Chinese medicated diet for hypertension”, Hong Kong J. Tradi. Chin. Med. (Chin.) 2013, 8(2): 66-69.

•    Li M.* (2013) “The commonly used ten Chinese medicines on the clinical treatment of dementia”, Hong Kong J. Tradit. Chin. Med. (Chin.) 2013; 8(1): 55-58.

•    Lu J.H., Song J.X., Durairajan S.S.K., Liu L.F., Li M.* (2012) “Chinese herbal medicinal Corynoxine B promotes the clearance of pathogenic protein aggregations associated with Parkinson’s disease via inducing autophagy”, ACTA Biophysica Sinica. (Suppl.1) 2012; 28(7):21.

•    Durairajan S.S.K., Liu L.F., Lu J.H., Chen L.L., Yuan Q.J., Chung S.K., Huang L., Li X.S., Huang J.D., Li M.* (2012) “Berberine Ameliorates Beta-amyloid Pathology, Gliosis and Cognitive Impairment in an Alzheimer's Disease Transgenic Mouse Model”, Neurobiol. Aging 2012; 33: 2903-2919.

•    Lu J.H., Tan J.Q., Durairajan S.S.K., Liu L.F., Zhang Z.H., Ma L., Shen H.M., Chan H.Y.,* Li M.* (2012) “Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy”, Autophagy. 2012; 8(1):98-108. (Erratum in Autophagy. 2012; 8(5): 864-866.)

•    Chua K.K., Chau C.S., Li M.* (2012) “Experimental and clinical research literature review of Tianma Gouteng Yin on the treatment of Parkinson's disease”, Hong Kong J. Tradi. Chin. Med. (Chin.) 2012; 7(4): 66-70.

•    Chua K.K., Li M.* (2012) “Literature Review and Data Analysis of Di-tan Decoction on Experimental and Clinical Study of Dementia”, Hong Kong J. Tradi. Chin. Med. (Chin.) 2012; 7(2): 72-75.

•    Man S.C., Chan K.W., Lu J.H., Durairajan S.S.K., Liu L.F., Li M. * (2012) “Systematic Review on the Safety and Efficacy of Herbal Medicine for the Treatment of Vascular Dementia”, Evid. Based Complement. Alternat. Med.  2012; DOI:10.1155/ecam/2012/426215.

•    Hui M.L., Chua K.K., Li M.* (2011) “A literature Review on the Treatment of Chinese Medicine in Neurodegenerative Diseases through Supplying Kidney Qi, Promote Blood Circulation and Dispel Phlegm”, Hong Kong J. Tradi. Chin. Med. (Chin.) 2011; 6(4): 35-40.

•    Liu L.F., Durairajan S.S.K., Lu J.H., Koo I., Li M. * (2011) “In Vitro Screening on Amyloid Precursor Protein Modulation of Plants used in Ayurvedic and Traditional Chinese Medicine for Memory Improvement”, J. Ethnopharmacol. 2011; DOI: 10.1016/j.jep.2011.08.065.

•    Duriarajan S.S.K., Liu L.F., Lu J.H, Koo I., Chung S.K., Maruyama K., Huang J.D., Li M.* (2011) “Beberine Inhibits Abeta Production, Plaque Formation, Gliosis and Cognitive Deterioration in a Transgenic Mouse Model of Alzheimer’s disease”, Neurodegener. Dis. 2011; 8 (Suppl.1), DOI: 10.1159/ 000327701.

•    Durairajan S.S.K., Liu L.F., Lu J.H., Koo I., Maruyama K., Chung S. K., Huang J.D.,* Li M.* (2011) “Stimulation of Non-amyloidogenic Processing of Amyloid Precursor Protein by Cryptotanshinone Involves Activation and Translocation of ADAM-10 and PKC-alpha”, J. Alzheimer’s Dis. 2011; 25: 245-262.

•    Lu J.H., Ardah M.T., Durairajan S.S.K., Liu L.F., Xie L.X., Fong W.F., Hasan M. Y., Huang J.D., El-Agnaf M. A. Omar,* Li M.* (2011) “Baicalein Inhibits Formation of Alpha-synuclein Oligomers within Living Cells and Prevents Abeta Fibrillation and Oligomerization”, ChemBioChem. 2011;12:615-624.

•    Kum W.F., Durairajan S.S.K., Bian Z.X., Lam Y.C., Man S.C., Xie L.X., Lu J.H., Huang X.Z., Li M.* (2011) “Treatment of Idiopathic Parkinson’s Disease with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Pilot Clinical Study”, Evid. Based Complement. Alternat. Med. 2011;724353.

•    Li M. * (2010) “The knowledge of Chinese medicine and its treatment strategies to the dementia”,  Hong Kong J. Tradi. Chin. Med. (Chin.) 2010, 5(4): 10-14.

•    Xie L.X., Durairajan S.S.K., Lu J.H., Liu C.L., Kum W.F., Wu W.K., Han D., Liao F.L., Huang J.D., Li M.* (2010) “The Effect of Salvianolic acid B Combined with Laminar Shear Stress on TNF-alpha stimulated Adhesion Molecule Expression in Human Aortic Endothelial Cells”, Clin. Hemorhe. Mecro. 2010; 44:245-258.

•    Chan W.H., Li M.* (2010) “The Study of the Pathogenesis and Applications of Prescriptions of Palpitation from Ancient Literatures”, Hong Kong J. Tradi. Chin. Med. (Chin.) 2010; 5(2): 16-18.

•    Chan W.S., Durairajan S.S.K., Lu J.H., Xie L.X., Wang Y., Kum W.F., Koo I., Yung K.K.L., Li M.* (2009) “The Neuroprotective Effects of Astragaloside IV (AS-IV) in 6-OHDA-treated Nigral Primary Cell Culture”, Neurochem. Int. 2009; 55: 414-422.

•    Kum W. F., Gao J., Durairajan S.S.K., Man S.C., Xie L.X., Lu J.H. Fong W.L., Li M.* (2009) “Risk Factors in Development of Motor Complications in Chinese Patients with Idiopathic Parkinson’s disease”, J. Clin. Neurosci. 2009; 16: 1034-1037.  

•    Lam Y. C., Kum W.F., Lu J.H., Durairajan S.S.K., Man S. C., Xu M., Zhang X. F., Huang X. Z., Li M.* (2008) “Efficacy and Safety of Acupuncture for Idiopathic Parkinson’s disease: A Systematic Review”, J. Altern. Complem. Med. 2008; 14(6): 663-671.

•    Xie L.X., Durairajan S.S.K., Liu C.L., Lu J.H., Kum W. F., Huang J. D., Liao F.L., Li M.* (2008) “The Effect of Salvianolic Acid B on TNF-a-stimulated Adhesion Molecule Expression under Flow Condition in Endothelial Cells”, Biorheology 2008; 45(1, 2): Suppl.42-43.

•    Wang Z., Li M, Wu W.K., Tan H.M., Geng D.F. (2008) “Ginsenoside Rb1 Preconditioning Protects against Myocardial Infarction after Regional Ischemia and Reperfusion by Activation of Phosphatidylinositol-3-kinase Signal Transduction”,  Cardiovasc Drugs Ther. 2008; 22(6):443-452.

•    Man S.C., Durairajan S.S.K., Kum W. F., Lu J.H., Huang J.D., Cheng C.F., Chung V., Xu M., Li M. * (2008) “Systematic Review of the Efficacy and Safety of Herbal Medicines for Alzheimer’s Disease”, J. Alzheimer’s Dis. 2008; 14(2): 209-223.

•    Li M.*, Zhao M.Q., Durairajan S.S.K., Xie L. X., Zhang H.X., Kum W. F., Goto S., Liao F.L. (2008) “Protective Effect of Tetramethylpyrazine and Salvianolic Acid B on Apoptosis of Rat Cerebral Microvascular Endothelial Cell under High Shear Stress”,  Clin. Hemorhe. Mecro. 2008; 38:177-187.

•    Durairajan S.S.K., Yuan Q.J., Xie L.X., Chan W.S., Kum W.F., Koo I., Liu C.L., Song Y.Q., Huang  J.D.*, Klein W.L., Li M.* (2008) “Salvianolic Acid B Inhibits Aβ Fibril Formation, Disaggregates Preformed Fibrils, and Protects Against Aβ-induced Cytotoxicity”, Neurochem. Int. 2008; 52: 741-750.

•    Zhang H.Q., Yau Y.F., Wong M.S., Man O.Y., He Y.Y., Chan N., Li M. (2008) “Chinese Medicine Formula DSQRL versus Glucocorticoids for the Treatment of Experimental Pulmonary Fibrosis”, J. Ethnopharmacol. 2008; 116: 318-324.

•    Liu C.L., Xie L. X., Li M.,* Kumar D.S.S., Goto S., Huang J.D.* (2007) “Salvianolic Acid B Inhibits Hydrogen Peroxide-Induced Endothelial Cell Apoptosis through Regulating PI3K/Akt Signaling”, PLoS ONE 2007; DOI: 10.1371/ journal.pone.0001321. 2007.12.19

•    Zhang H.Q., Yau Y.F., Szeto K.Y., Chan W.T., Wong J., Li M. (2007) “Therapeutic Effect of Chinese Medicine Formula DSQRL on Experimental Pulmonary Fibrosis”, J. Ethnopharmacol. 2007; 109: 543-546.

•    Chung V., Liu L., Bian Z.X., Zhao ZZ., Fong W.L., Kum W.F., Gao J., Li M.* (2006) “The Efficacy and Safety of Herbal Medicines for Idiopathic Parkinson’s Disease: a Systematic Review”, Mov. Disord. 2006; 21: 1709-1715.

•    Liao F. L., Li M., Han D., Cao J., Chen K.J. (2006) “Biomechanopharmacology – a New Borderline Discipline”, Trends. Pharmacol. Sci. 2006; 27:287-289.

•    Bian Z.X., Zhang G.S., Wong K.L., Hu X.G., Liu L., Yang Z.J., Li M. (2006) “Inhibitory Effects of Magnolol on Distal Colon of Guinea Pig in Vitro”, Biol. Pharm. Bull. 2006; 29: 790-795.

•    Zhao C., Li M., Luo Y.F., Wu W.K. (2006) “Isolation and Structural Characterization of an Immunostimulating Polysaccharide from Fuzi, Aconitum carmichaeli”, Carbohydrate Res. 2006; 341: 485-491.

•    Leung C.Y., Liu L., Wong Ricky N.S., Zeng Y. Y., Li M., Zhou H. (2005) “Saikosaponin-d inhibits T cell activation through the modulation of PKCθ, JNK and NF-κB transcription factor”, J. Biochem. Biophys. Res. Commun. 2005; 338:1920-1927.

•    Liao F.L., Cao J., Li M., You Y. (2005) “The Methodology in Biomechanopharmacology”,  Biorheology  2005; 42: Suppl. 58-59.

•    Li M.,* Zhao M.Q., Zhang H.X., Goto S., Wu W.K., Liao F.L. (2005) “Anti-apoptosis Effects of Tetramethylpyrazine and Salvianolic Acid B on Rat Cerebral Microvascular Endothelial Cells under High Shear Stress”, Biorheology 2005; 42: Suppl. 57.

•    Jiang Z.H., Wang J.R., Li M., Liu Z.Q., Chau K.Y., Zhao C., Liu L.(2005) “Two Novel Hemiterpene Glucosides with Potent Anti-Platelet Aggregation Activities from Ilex Pubescens”,  J. Nat. Prod. 2005; 68: 397-399.

•    Bian Z.X., Liu L., Li M. (2004) “The Treatment of TCM on Post-SARS Syndrome”, J. Trad. Chin. Med. (Chin.) 2004; 45(3):236.

•    Li M.,* Zhao C., Wong Ricky N.S., Goto S., Wang Z.M., Liao F.L. (2004) “Inhibition of Shear-induced Platelet Aggregation in Rat by Tetramethylpyrazine and Salvianolic acid B”, Clin. Hemorheol. Microcirc.2004; 31:97-103.

•    Li M.,* Wu W.K., Liu L., Liao F.L., Handa S., Goto S. (2004) “Specific Inhibiting Effects of Ilexonin A on von Willebrand Factor-dependent Platelet Aggregation Under High Shear Rate”, Chin. Med. J.,(Eng.). 2004; 117: 241-246 .

•    Goto S., Tamura N., Li M., Handa M., Ikeda Y., Handa S., Ruggeri Z.M. (2003) “Different Effects of Various Anti-GPIIb-IIIa Agents on Shear-Induced Platelet Activation and Expression of Procoagulant Activity”, J. Thromb. Haemost. 2003; 1: 2022-2030.

•    Li M.,* Liu L., Zhang X.H., Yeh M.-L., Liao F.L. (2003) “Correlation between Shear Induced Platelet Aggregation and Viscosity Parameter for Platelet-rich Plasma”, Clin. Hemorheol Microcirc. 2003; 28:259-261.

•    Li M.,* Liao F.L., Handa S., Goto S., Liu L. (2002) “Characteristics of the Chinese Herbal Medicines, Ligustrazine Hydrochloride on Platelet Thrombus Formation Occurring Under Flow”,  Biorheology 2002; 39: Suppl.463.

•    Izumi Y., Li M. (2001) “The Initial Exploration of Chinese Medical Diagnosis (II)”. East. Med. (Jap.) 2001; 17: 71-76.

•    Izumi Y., Li M. (2001) “The Initial Exploration of Chinese Medical Diagnosis (I)”. East. Med. (Jap.) 2001; 16: 73-77.

•    Izumi Y., Li M. (2001) “The Entrance of Learning Chinese Medicine”. J. Kanagawa Med. Society. (Jap.) 2001; 27:185-192.

•    Izumi Y., Li M. (2001) “The Chinese Medical Treatment on Neurological Disease”. Clin. Neurosci. (Jap.) 2001; 19: 144-145.

•    Li M., Handa S., Ikeda Y., Goto S. (2001) “Specific Inhibiting Characteristics of Tetramethylpyrazine, one of the Active Ingredients of the Chinese Herbal Medicine ‘Chuanxiong’, on Platelet Thrombus Formation under High Shear Rates ”, Thromb. Res.2001; 104: 15-28.

•    Niu X.L., Ichimori K., Yang X., Hirota Y., Hoshiai K., Li M., Nakazawa H. (2000) “Tanshinone II-A Inhibits Low Density Lipoprotein Oxidation in Vitro”, Free Radical. Res. 2000; 33:305-312.

•    Goto S., Ichikawa N., Li M., Goto M., Kim J.Y., Yoshida M., Ikeda Y., Handa S. (2000) “Platelet Surface P-selectin Molecules Increased after Exposing Platelet to a High Shear Flow”. Inter. Angio. 2000; 19:147-151.

•    Izumi Y., Li M. (2000) “A Clinical Case Report of Acute Thalamic Dementia Was Treated by Powder of Angelicae Sinensis and Paeoniae”, J. Uni. Guangzhou Trad. Chin. Med. (Chin.) 2000; 17: 358-359.

•    Li M., Goto S., Sakai H., Kim J.Y., Ichikawa N., Yoshida M., Ikeda Y., Handa S. (2000) “Enhanced Shear-Induced von Willebrand Factor Binding to Platelets in Acute Myocardial Infarction”, Thromb. Res. 2000; 100:251-261.

•    Kim J.Y., Goto S., Sakai H., Ichikawa N., Yoshida M., Li M., Miyuki O., Ikeda Y., Handa S. (1999) “The Effect of Plasma Concentration on Shear-induced von Willebrand Factor-mediated Platelet Aggregation”, Jap. J. Thromb. Haemost. 1999; 10:251-259.





Copyright ©2013 - 2015 Mr. and Mrs. Ko Chi Ming Centre for Parkinson’s Disease Research